ECLIPSE TOPICAL ANESTHETIC- lidocaine hydrochloride cream
Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.
Lidocaine HCL 4.00% w/w
For temporary relief of pain and itching due to minor skin irritation.
For external use only
Avoid contact with eyes
Do not use in large quantities, particularly over raw surfaces or blistered areas
Stop use and ask a doctor if
• Condition worsens, or if symptoms persist for more than 7 days or clear up and occur again within a few days. Discontinue use.
Keep out of reach of children
• If product is swallowed, get medical help or contact a Poison Control Center right away.
For adults and children two-years or older: Apply to affected area not more than 3 or 4 times daily. Children under 2 years of age: consult a physician. Apply in a circular motion for 50 to 60 seconds.
Aqua (Deionized Water), Arnica Montana Flower Extract, C13-14 Isoparaffin, Chrondroitin Sulfate, Emu Oil, Ethoxydiglycol, Ethylhexyglycerin, Glucosamine Sulfate, Isopropyl Palmitate, Laureth-7, Melaleuca Alternifolia (Tea Tree) Oil, Methylsulfonylmethane (MSM), Phenoxyethanol, Polyacrylamide, Propylene Glycol, Stearic Acid, Triethanolamine.
Protect this product from excessive heat and direct sun.
FDA Registered: NDC No. 54723-667-10
| ECLIPSE TOPICAL ANESTHETIC |
lidocaine hydrochloride cream
|Labeler — Sambria Pharmaceuticals (078676259)|
|A.I.G. Technologies, Inc.||171837367||manufacture (54723-667)|
|JP Packaging LLC||151369456||repack (54723-667)|
Revised: 08/2018 Sambria Pharmaceuticals
DrugInserts.com provides trustworthy package insert and label information about marketed drugs as submitted by manufacturers to the US Food and Drug Administration. Package information is not reviewed or updated separately by DrugInserts.com. Every individual package label entry contains a unique identifier which can be used to secure further details directly from the US National Institutes of Health and/or the FDA.